Literature DB >> 8691319

Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma--a diagnostic tool in minimally invasive biopsies.

A P McManus1, M A O'Reilly, K P Jones, B A Gusterson, C D Mitchell, C R Pinkerton, J M Shipley.   

Abstract

The identification of t(2;13)(q35;q14) is a useful aid in the accurate diagnosis of rhabdomyosarcoma, distinguishing it from other small round cell tumours and supporting the distinction between alveolar and embryonal forms. Cytogenetic analysis is difficult and with the increased use of minimally invasive biopsy methods and primary chemotherapy, adequate tumour material is not always available. To overcome these difficulties, two-colour interphase fluorescence in situ hybridization (FISH) to detect t(2;13)(q35;q14) was developed and its utility in assessing minimally invasive biopsies was investigated. Two cosmid clones which mapped proximal or distal to the breakpoint region 13q14 and one yeast artificial chromosome clone that mapped distal to the 2q35 breakpoint were identified. In interphase cells containing t(2;13)(q35;q14), the configuration of cosmid and yeast artificial chromosome signals demonstrated the presence of the translocation. Five cases of rhabdomyosarcoma were analysed by interphase FISH. The t(2;13)(q35;q14) was detected in all four alveolar tumours and was confirmed by cytogenetics in two cases, but was absent in one embryonal tumour. This sensitive detection method is applicable to minimal amounts of fresh or frozen tumour.

Entities:  

Mesh:

Year:  1996        PMID: 8691319     DOI: 10.1002/(SICI)1096-9896(199604)178:4<410::AID-PATH508>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Use of nonbreakpoint DNA probes to detect the t(X;18) in interphase cells from synovial sarcoma: implications for detection of diagnostic tumor translocations.

Authors:  M Zilmer; C P Harris; D S Steiner; L F Meisner
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.

Authors:  J Anderson; J Renshaw; A McManus; R Carter; C Mitchell; S Adams; K Pritchard-Jones
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

3.  The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.

Authors:  Khin Thway; Jayson Wang; Dorte Wren; Melissa Dainton; David Gonzalez; John Swansbury; Cyril Fisher
Journal:  Virchows Arch       Date:  2015-04-26       Impact factor: 4.064

Review 4.  Molecular genetics of pediatric soft tissue tumors: clinical application.

Authors:  Chung-Che Chang; Vinod B Shidham
Journal:  J Mol Diagn       Date:  2003-08       Impact factor: 5.568

Review 5.  Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature.

Authors:  D A Morgenstern; H Rees; N J Sebire; J Shipley; John Anderson
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

6.  Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?

Authors:  J Anderson; T Gordon; A McManus; T Mapp; S Gould; A Kelsey; H McDowell; R Pinkerton; J Shipley; K Pritchard-Jones
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

Review 7.  Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).

Authors:  Margherita Cerrone; Monica Cantile; Francesca Collina; Laura Marra; Giuseppina Liguori; Renato Franco; Annarosaria De Chiara; Gerardo Botti
Journal:  Int J Mol Med       Date:  2014-04-04       Impact factor: 4.101

8.  An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.

Authors:  Afua Mensah; Claire Mulligan; Jackie Linehan; Sandra Ruf; Aideen O'Doherty; Beata Grygalewicz; Janet Shipley; Juergen Groet; Victor Tybulewicz; Elizabeth Fisher; Sebastian Brandner; Dean Nizetic
Journal:  BMC Dev Biol       Date:  2007-11-29       Impact factor: 1.978

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.